Tonix Pharmaceuticals Holding Corp. (TNXP) Net Income by Year
Tonix Pharmaceuticals Holding Corp. reported a net loss of $124.0M in fiscal year 2025. This represents an increase of 4.6% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to a $159.7M net loss. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Tonix Pharmaceuticals Holding Corp. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
TNXP Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | TTM | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$159.7M | -$124.0M+4.6% | -$130.0M-11.5% | -$116.7M-5.8% | -$110.2M-19.4% | -$92.3M-82.9% | -$50.5M-76.3% | -$28.6M-9.7% | -$26.1M-23.5% | -$21.1M+45.6% | -$38.8M+19.2% | -$48.1M-74.0% | -$27.6M-153.7% | -$10.9M-15.2% | -$9.4M | N/A |
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
TNXP Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Tonix Pharmaceuticals Holding Corp. financials
Frequently Asked Questions
What was Tonix Pharmaceuticals Holding Corp.'s net income in fiscal year 2025?
Tonix Pharmaceuticals Holding Corp. reported a net loss of $124.0M in fiscal year 2025.
How fast is Tonix Pharmaceuticals Holding Corp.'s net income growing?
Tonix Pharmaceuticals Holding Corp. (TNXP) net income rose by 4.6% year over year, from -$130.0M to -$124.0M in fiscal year 2025.
What is Tonix Pharmaceuticals Holding Corp.'s net income over the last twelve months?
Tonix Pharmaceuticals Holding Corp. (TNXP) reported a $159.7M net loss over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
What was Tonix Pharmaceuticals Holding Corp.'s net income in the most recent quarter?
Tonix Pharmaceuticals Holding Corp. (TNXP) reported -$40.6M in net income in Q2 2026. This represents a decrease of 43.4% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Tonix Pharmaceuticals Holding Corp. (TNXP) reported on that line in every period on record.